Effects of phytoestrogens on the activity and growth of primary breast cancer cells ex vivo

Journal of Obstetrics and Gynaecology Research

Volumn 45, Issue 7, 2019, Pages 1352-1362

  Chen, Fang Ping ^a,b   Chien, Mei Hua ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

17 estradiol; genistein; mitochondria Caspase cascade; primary breast cancer cells; quercetin; resveratrol

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; QUERCETIN; RESVERATROL; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; ESTROGEN RECEPTOR ALPHA, HUMAN; PHYTOESTROGEN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS ASSAY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY ASSAY; CONTROLLED STUDY; DRUG EFFECT; EX VIVO STUDY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; WESTERN BLOTTING; APOPTOSIS; BREAST TUMOR; CELL SURVIVAL; FEMALE; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENISTEIN; HUMANS; PHYTOESTROGENS; QUERCETIN; RESVERATROL;

EID: 85066023825     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/jog.13982     Document Type: Article

References (32)

1. Yildiz F. Phytoestrogens in Functional Foods. New York: Taylor & Francis Ltd., 2005; 210–211.
2. Kolonel LN. Variability in diet and its relation to risk in ethnic and migrant groups. Basic Life Sci 1988; 43: 129–135.
3. Parkin DM. Cancers of the breast, endometrium and ovary: Geographic correlations. Eur J Cancer Clin Oncol 1989; 25: 1917–1925.
4. Rose DP, Boyar AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer 1986; 58: 2363–2371.
5. Messina M, McCaskill-Stevens W, Lampe JW. Addressing the soy and breast cancer relationship: Review, commentary, and workshop proceedings. J Natl Cancer Inst 2006; 98: 1275–1284.
6. Boyapati SM, Shu XO, Ruan ZX et al. Soyfood intake and breast cancer survival: A followup of the Shanghai breast cancer study. Breast Cancer Res Treat 2005; 92: 11–17.
7. Thompson LU, Chen JM, Li T, Strasser-Weippl K, Goss PE. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res 2005; 11: 3828–3835.
8. Benassayag C, Perrot-Applanat M, Ferre F. Phytoestrogens as modulators of steroid action in target cells. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 777: 233–248.
9. Tuohy PG. Soy infant formula and phytoestrogens. J Paediatr Child Health 2003; 39: 401–405.
10. Chen FP, Chien MH. Phytoestrogens induce apoptosis through a mitochondria/Caspase pathway in human breast cancer cells. Climacteric 2014; 17: 385–392.
11. Chen FP, Chien MH. Phytoestrogens induce differential effects on both normal and malignant human breast cells in vitro. Climacteric 2014; 17: 682–691.
12. Harris DM, Besselink E, Henning SM, Go VLW, Heber D. Phytoestrogens induce differential estrogen receptor alpha- or beta-mediated responses in transfected breast cancer cells. Exp Biol Med 2005; 230: 558–568.
13. Speirs V, Green AR, Walton DS et al. Short-term primary culture of epithelial cells derived from human breast tumours. Br J Cancer 1998; 78: 1421–1429.
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55–63.
15. Negoescu A, Guillermet C, Lorimier P, Brambilla E, Labat-Moleur F. Importance of DNA fragmentation in apoptosis with regard to TUNEL specificity. Biomed Pharmacother 1998; 52: 252–258.
16. Alipour S, Jafari-Adli S, Eskandari A. Benefits and harms of phytoestrogen consumption in breast cancer survivors. Asian Pac J Cancer Prev 2015; 16: 3091–3096.
17. Pozo-Guisado E, Alvarez-Barrientos A, Mulero-Navarro S, Santiago-Josefat B, Fernandez-Salguero PM. The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: Cell-specific alteration of the cell cycle. Biochem Pharmacol 2002; 64: 1375–1386.
18. Pozo-Guisado E, Merino JM, Mulero-Navarro S et al. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB. Int J Cancer 2005; 115: 74–84.
19. Chen FP, Chien MH, Chern IYY. Impact of lower concentrations of phytoestrogens on the effects of estradiol in breast cancer cells. Climacteric 2015; 18: 574–581.
20. Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet 2013; 45: 1127–1133.
21. Cree IA, Glaysher S, Harvey AL. Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue. Curr Opin Pharmacol 2010; 10: 375–379.
22. Gillet JP, Calcagno AM, Varma S et al. Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance. Proc Natl Acad Sci U S A 2011; 108: 18708–18713.
23. Seo HS, Denardo DG, Jacquot Y et al. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Breast Cancer Res Treat 2006; 99: 121–134.
24. Schmitt E, Lehmann L, Metzler M, Stopper H. Hormonal and genotoxic activity of resveratrol. Toxicol Lett 2002; 136: 133–142.
25. van der Woude H, Ter Veld MG, Jacobs N, van der Saag PT, Murk AJ, Rietjens IM. The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor. Mol Nutr Food Res 2005; 49: 763–771.
26. Magee PJ, Rowland IR. Phyto-oestrogens, their mechanism of action: Current evidence for a role in breast and prostate cancer. Br J Nutr 2004; 91: 513–531.
27. van Landeghem AA, Poortman J, Nabuurs M, Thijssen JH. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res 1985; 45: 2900–2906.
28. Jefcoate CR, Liehr JG, Santen RJ et al. Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr 2000; 27: 95–112.
29. Elmlinger MW, Kühnel W, Ranke MB. Reference ranges for serum concentrations of lutropin (LH), follitropin (FSH), estradiol (E2), prolactin, progesterone, sex hormone-binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEAS), cortisol and ferritin in neonates, children and young adults. Clin Chem Lab Med 2002; 40: 1151–1160.
30. Kuhl H. Pharmacology of estrogens and progestogens: Influence of different routes of administration. Climacteric 2005; 8 (Suppl 1): S3–S63.
31. Miodini P, Fioravanti L, Di Fronzo G, Cappelletti V. The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function. Br J Cancer 1999; 80: 1150–1155.
32. Schmidt S, Michna H, Diel P. Combinatory effects of phytoestrogens and 17beta-estradiol on proliferation and apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 2005; 94: 445–449.